Xie Yili Kevin 4
4 · HUMANIGEN, INC · Filed Jan 4, 2022
Insider Transaction Report
Form 4
HUMANIGEN, INCHGEN
Xie Yili Kevin
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-12-31$2.84/sh+4,674$13,274→ 4,674 totalExercise: $3.72From: 2021-12-31Exp: 2031-12-30→ Common Stock (4,674 underlying)
Footnotes (1)
- [F1]The stock option was granted to Mr. Xie in lieu of $13,282 of cash compensation otherwise payable to Mr. Xie in respect of his services as a director during the fourth quarter of 2021.